首页> 外文期刊>Journal of Neuroimmunology: Official Bulletin of the Research Committee on Neuroimmunology of the World Federation of Neurology >VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNgamma synthesis by T cells.
【24h】

VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNgamma synthesis by T cells.

机译:VIP和PACAP抑制LPS刺激的巨噬细胞中IL-12的产生。 T细胞对IFNγ合成的后续影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Since IL-12 plays a central role against intracellular pathogens, and contributes to the pathogenesis of immune diseases, its regulation is essential. This study examines the effect of two neuropeptides, vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP), on interleukin-12 (IL-12) production. VIP/PACAP inhibit IL-12 dose-dependently. Type 1 VIP receptor (VPAC1), and to a lesser degree type 2 VIP receptor (VPAC2), mediate the inhibition of IL-12, primarily through the cAMP/PKA pathway. VIP/PACAP inhibit the production of IL-12, IL-6, tumor necrosis factor alpha (TNFalpha), and interferon gamma (IFNgamma) in vivo in endotoxemic mice. The presence of VIP/PACAP in the lymphoid organs and the specific effects on cytokine production offer a physiological basis for their immunomodulatory role in vivo.
机译:由于IL-12对细胞内病原体起着核心作用,并有助于免疫疾病的发病,因此其调节至关重要。这项研究检查了两种神经肽,血管活性肠肽(VIP)和垂体腺苷酸环化酶激活多肽(PACAP)对白介素12(IL-12)产生的影响。 VIP / PACAP剂量依赖性地抑制IL-12。 1型VIP受体(VPAC1)和2型VIP受体(VPAC2)主要通过cAMP / PKA途径介导IL-12的抑制。 VIP / PACAP可在内毒素血症小鼠体内抑制IL-12,IL-6,肿瘤坏死因子α(TNFalpha)和干扰素γ(IFNgamma)的产生。淋巴器官中VIP / PACAP的存在以及对细胞因子产生的特定作用为其体内免疫调节作用提供了生理基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号